AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26156818 — intervention group
Group type: EXPERIMENTAL
Intervention: Brenner's Integrated Psychological Therapy (IPT) cognitive training, delivered once a week for 6 months
Number of subjects: 28
Study 26156818 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 23870642 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron substitution (ferric carboxymaltose)
Number of subjects: 459
Study 23870642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study 21632197 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based personalized feedback intervention (Check Your Drinking [CYD] screener)
Number of subjects: 92
Study 21632197 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 92
Study 18378614 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial Contrast Echocardiography (MCE)
Number of subjects: 63
Study 18378614 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Photon Emission Computed Tomography (SPECT)
Number of subjects: 63
Study 18378614 — intervention group
Group type: COMPARATOR
Intervention: LBBB patients (group A)
Number of subjects: 63
Study 18378614 — intervention group
Group type: COMPARATOR
Intervention: LBBB patients (group A) and left ventricular ejection fraction-matched control subjects (group B)
Number of subjects: 63
Study 16616221 — intervention group
Group type: EXPERIMENTAL
Intervention: Replanting the inferior mesentery artery (IMA)
Number of subjects: 160
Study 16616221 — intervention group
Group type: COMPARATOR
Intervention: Ligation of the inferior mesentery artery (IMA)
Number of subjects: 160
Study 12576167 — intervention group
Group type: COMPARATOR
Intervention: Levetiracetam with comedication not affecting drug metabolizing enzymes (gabapentin, lamotrigine, vigabatrin)
Number of subjects: 590
Study 12576167 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam with enzyme‐inducing AEDs (carbamazepine, phenytoin, phenobarbital, primidone)
Number of subjects: 590
Study 12576167 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam with valproic acid
Number of subjects: 590
Study 11083353 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RA
Number of subjects: 18
Study 11083353 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 18
Study 8803722 — intervention group
Group type: EXPERIMENTAL
Intervention: Nipradilol
Number of subjects: 18
Study 8803722 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (Control)
Number of subjects: 18
Study 1617822 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 0
Study 1617822 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin
Number of subjects: 0
Study 1617822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30608606 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein hydrolysate B
Number of subjects: 20
Study 30608606 — intervention group
Group type: COMPARATOR
Intervention: Intact caseinate
Number of subjects: 20
Study 30608606 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein hydrolysate A
Number of subjects: 20
Study 29970168 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle‐Integrated Functional Exercise Program
Number of subjects: 0
Study 27502103 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan 2 mg/kg, given by nasogastric tube twice daily for ≥48 hours and up to 1 day after iNO weaning.
Number of subjects: 21
Study 27502103 — intervention group
Group type: COMPARATOR
Intervention: Placebo, given by nasogastric tube twice daily for ≥48 hours and up to 1 day after iNO weaning.
Number of subjects: 21
Study 24513129 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-shock pause <10s
Number of subjects: 2006
Study 24513129 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-shock pause <20s
Number of subjects: 2006
Study 24513129 — intervention group
Group type: COMPARATOR
Intervention: Post-shock pause
Number of subjects: 2006
Study 24513129 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurologically intact survival (Modified Rankin Score ≤ 3)
Number of subjects: 2006
Study 23011561 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 64
Study 23011561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 23011561 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 64
Study 20540635 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 31
Study 20540635 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol (500 mg/day)
Number of subjects: 31
Study 20540635 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin and Probucol
Number of subjects: 31
Study 17932160 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cardiac resynchronisation and implantable cardioverter defibrillator therapy
Number of subjects: 8307
Study 17932160 — intervention group
Group type: COMPARATOR
Intervention: Implantable defibrillator therapy
Number of subjects: 8307
Study 17932160 — intervention group
Group type: COMPARATOR
Intervention: Resynchronisation therapy alone
Number of subjects: 8307
Study 17932160 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 8307
Study 15531565 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (breathing 12% O(2)) during 20-min 60 degrees head-upright tilt
Number of subjects: 16
Study 15531565 — intervention group
Group type: COMPARATOR
Intervention: Normoxia during 20-min 60 degrees head-upright tilt
Number of subjects: 16
Study 15531565 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia during 20-min 60 degrees head-upright tilt
Number of subjects: 16
Study 15531565 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 16
Study 12095068 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (ALA) in combination with photodynamic therapy (PDT)
Number of subjects: 0
Study 10827645 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic clinical supervision
Number of subjects: 22
Study 10827645 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' view of the effects from clinical supervision
Number of subjects: 22
Study 10827645 — intervention group
Group type: EXPERIMENTAL
Intervention: Work-Related Strain Inventory (WRSI)
Number of subjects: 22
Study 10827645 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with Nursing Care and Work Questionnaire (SNCW)
Number of subjects: 22
Study 10827645 — intervention group
Group type: EXPERIMENTAL
Intervention: Sense of Coherence scale (SOC)
Number of subjects: 22
Study 7824141 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological evaluation at moderate stage of the disease in 6 subjects
Number of subjects: 34
Study 7824141 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropathologic changes typical of AD
Number of subjects: 34
Study 7824141 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic marker D14S43
Number of subjects: 34
Study 7824141 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of seizures
Number of subjects: 34
Study 7824141 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoclonus and extrapyramidal signs
Number of subjects: 34
Study 2337713 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 40
Study 2337713 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 40
Study 231737 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen for three months
Number of subjects: 12
Study 231737 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31796029 — intervention group
Group type: EXPERIMENTAL
Intervention: Managerial and organizational transformation program for empowerment lasting 12 months
Number of subjects: 1000
Study 31796029 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 1000
Study 28987643 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load resistance training (HL) at 70% of one repetition maximum (1-RM)
Number of subjects: 36
Study 28987643 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load blood flow restricted (BFR) resistance training at 30% 1-RM with vascular restriction
Number of subjects: 36
Study 28987643 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) performing light upper body resistance and flexibility training
Number of subjects: 36
Study 28987643 — intervention group
Group type: EXPERIMENTAL
Intervention: All training groups (HL and BFR)
Number of subjects: 36
Study 25056413 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic scaling followed by repeated antimicrobial photodynamic therapy (PDT)
Number of subjects: 27
Study 25056413 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic scaling (US) alone
Number of subjects: 27
Study 25056413 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 27
Study 25056413 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT
Number of subjects: 27
Study 22573244 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rinse containing zinc and chlorhexidine
Number of subjects: 21
Study 22573244 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rinse with adjunct tongue scraping
Number of subjects: 21
Study 22573244 — intervention group
Group type: COMPARATOR
Intervention: Negative control rinse alone
Number of subjects: 21
Study 22573244 — intervention group
Group type: COMPARATOR
Intervention: Control and tongue scraping sequence
Number of subjects: 21
Study 21844095 — intervention group
Group type: EXPERIMENTAL
Intervention: State boredom
Number of subjects: 0
Study 19655213 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax AWS
Number of subjects: 0
Study 19655213 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope
Number of subjects: 0
Study 19655213 — intervention group
Group type: COMPARATOR
Intervention: Macintosh
Number of subjects: 0
Study 17366756 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdental Brushes (IDB)
Number of subjects: 10
Study 17366756 — intervention group
Group type: COMPARATOR
Intervention: Dental Floss (DF)
Number of subjects: 10
Study 15504872 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal administration of quinine (16 or 20 mg/kg)
Number of subjects: 60
Study 11679506 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 microg ethinyl oestradiol plus 75 microg gestodene
Number of subjects: 60
Study 11679506 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microg ethinyl oestradiol plus 150 microg desogestrel
Number of subjects: 60
Study 11679506 — intervention group
Group type: EXPERIMENTAL
Intervention: Pill users
Number of subjects: 60
Study 9477463 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifugal pump (Group B)
Number of subjects: 61
Study 9477463 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifugal pump with heparin-coated circuit (Group C)
Number of subjects: 61
Study 9477463 — intervention group
Group type: COMPARATOR
Intervention: Roller pump (Group A)
Number of subjects: 61
Study 7944879 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0
Study 7944879 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine hydrochloride
Number of subjects: 0
Study 7944879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3364308 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin B complex and vitamin C preparation
Number of subjects: 28
Study 3364308 — intervention group
Group type: COMPARATOR
Intervention: Nonsupplemented postoperative controls
Number of subjects: 28
Study 31662162 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute moderate-intensity exercise before memory encoding
Number of subjects: 0
Study 31662162 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute moderate-intensity exercise during memory consolidation
Number of subjects: 0
Study 31662162 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 0
Study 29178685 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple levels of antidepressant treatment
Number of subjects: 1953
Study 29178685 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of delayed remission
Number of subjects: 1953
Study 29178685 — intervention group
Group type: EXPERIMENTAL
Intervention: Final predictive model
Number of subjects: 1953
Study 25760423 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically engineered chondrocytes (6×10^6 cells)
Number of subjects: 27
Study 25760423 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically engineered chondrocytes (1.8×10^7 cells)
Number of subjects: 27
Study 23962096 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use, air-cushioned face mask (AM)
Number of subjects: 32
Study 23962096 — intervention group
Group type: COMPARATOR
Intervention: Reusable silicone face mask (SM)
Number of subjects: 32
Study 21872708 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary gastric electrical stimulation (tGES) for 72 hours during session 1
Number of subjects: 58
Study 21872708 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary gastric electrical stimulation (tGES) for 72 hours during session 2
Number of subjects: 58
Study 21872708 — intervention group
Group type: COMPARATOR
Intervention: Overall treatment effect across sessions
Number of subjects: 58
Study 19472534 — intervention group
Group type: EXPERIMENTAL
Intervention: Biaxial microincisional cataract surgery with enlargement of one incision to 2.8 mm
Number of subjects: 50
Study 19472534 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical control group
Number of subjects: 50
Study 17935024 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral laminectomy for bilateral decompression
Number of subjects: 50
Study 15060899 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolytic iron (66 mg/kg)
Number of subjects: 0
Study 15060899 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced iron (66 mg/kg)
Number of subjects: 0
Study 11135169 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 266
Study 11135169 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac valve operations
Number of subjects: 266
Study 9701188 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 IU vitamin E/d
Number of subjects: 88
Study 9701188 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 IU vitamin E/d
Number of subjects: 88
Study 9701188 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 IU vitamin E/d
Number of subjects: 88
Study 9701188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 8025741 — intervention group
Group type: EXPERIMENTAL
Intervention: ganciclovir 5 mg/kg once a day 5 d/wk (Group G)
Number of subjects: 25
Study 8025741 — intervention group
Group type: COMPARATOR
Intervention: acyclovir 800 mg four times a day (Group A)
Number of subjects: 25
Study 2557572 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin 15,000 AXaU/day
Number of subjects: 90
Study 2557572 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin 7,500 AXaU/day
Number of subjects: 90
Study 2557572 — intervention group
Group type: COMPARATOR
Intervention: Calcium heparin 5000 I.U. t.i.d.
Number of subjects: 90
Study 4548092 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 8
Study 4548092 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Fluorouracil (5 FU)
Number of subjects: 8
Study 4548092 — intervention group
Group type: COMPARATOR
Intervention: Standard endocrine therapy
Number of subjects: 8
Study 29654980 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Education with Clinical Hypnosis (PE + CH)
Number of subjects: 100
Study 29654980 — intervention group
Group type: COMPARATOR
Intervention: Pain Education (PE) alone
Number of subjects: 100
Study 28062311 — intervention group
Group type: EXPERIMENTAL
Intervention: TRPA1 antagonist A-967079
Number of subjects: 15
Study 28062311 — intervention group
Group type: EXPERIMENTAL
Intervention: TRPV1 inhibitor BCTC
Number of subjects: 15
Study 28062311 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride (acid-sensing ion channel blocker)
Number of subjects: 15
Study 28062311 — intervention group
Group type: COMPARATOR
Intervention: pH 4.3 continuous intraepidermal injection
Number of subjects: 15
Study 25759552 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intravariceal and esophageal mucosal sclerotherapy using small-volume sclerosant
Number of subjects: 38
Study 25759552 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic variceal ligation (EVL)
Number of subjects: 38
Study 23576329 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower neighborhood income
Number of subjects: 40827
Study 23576329 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted neighborhood income
Number of subjects: 40827
Study 21348897 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumour infiltrating lymphocytes (TIL) treatment in 80 patients
Number of subjects: 144
Study 21348897 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified how many patients)
Number of subjects: 144
Study 18468271 — intervention group
Group type: EXPERIMENTAL
Intervention: Orofacial myofunctional therapy (OMT)
Number of subjects: 28
Study 18468271 — intervention group
Group type: COMPARATOR
Intervention: Control group with TMD (Group CTMD)
Number of subjects: 28
Study 16224198 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (375-3000 mg/day)
Number of subjects: 0
Study 16224198 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (during double-blind phase)
Number of subjects: 0
Study 16224198 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate
Number of subjects: 0
Study 12964171 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine 60 mg/d
Number of subjects: 0
Study 12964171 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine 120 mg/d (60 mg b.i.d.)
Number of subjects: 0
Study 12964171 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine 40 mg/d (20 mg b.i.d.)
Number of subjects: 0
Study 12964171 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine 80 mg/d (40 mg b.i.d.)
Number of subjects: 0
Study 12964171 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine >/=60 mg
Number of subjects: 0
Study 12964171 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0
Study 9537485 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Nitric Oxide (NO) at 100 ppm
Number of subjects: 21
Study 9537485 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Nitric Oxide (NO) at 640 ppm
Number of subjects: 21
Study 9537485 — intervention group
Group type: COMPARATOR
Intervention: No Inhaled Nitric Oxide
Number of subjects: 21
Study 7635998 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (CMI)
Number of subjects: 6
Study 7635998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 2619917 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer-lactate
Number of subjects: 90
Study 2619917 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose at 5%
Number of subjects: 90
Study 2619917 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-2 x 1
Number of subjects: 90
Study 843186 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate psychotherapy treatment
Number of subjects: 0
Study 843186 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study 31546105 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Intervention (MBI)
Number of subjects: 3519
Study 31546105 — intervention group
Group type: COMPARATOR
Intervention: Relaxation program
Number of subjects: 3519
Study 31546105 — intervention group
Group type: COMPARATOR
Intervention: Teaching as usual
Number of subjects: 3519
Study 31077425 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided tacrolimus doses (0.125 mg/kg/day for CYP3A5*1/*1, 0.1 mg/kg/day for *1/*3, 0.08 mg/kg/day for *3/*3)
Number of subjects: 125
Study 31077425 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided tacrolimus doses
Number of subjects: 125
Study 31077425 — intervention group
Group type: COMPARATOR
Intervention: Conventional tacrolimus doses (0.1 mg/kg/day)
Number of subjects: 125
Study 27904905 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarucizumab (8 g as a 1-hour infusion)
Number of subjects: 2
Study 27904905 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarucizumab (4 g as a 5-minute infusion)
Number of subjects: 2
Study 27904905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 25096689 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (n=435)
Number of subjects: 868
Study 25096689 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care as usual (n=433)
Number of subjects: 868
Study 25096689 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 868
Study 25096689 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care as usual
Number of subjects: 868
Study 22995632 — intervention group
Group type: EXPERIMENTAL
Intervention: Maudsley Model of Anorexia Nervosa Treatment for Adults (MANTRA)
Number of subjects: 72
Study 22995632 — intervention group
Group type: COMPARATOR
Intervention: Specialist Supportive Clinical Management (SSCM)
Number of subjects: 72
Study 19440025 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser lithotripsy (LL)
Number of subjects: 55
Study 19440025 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic lithotripsy (PL)
Number of subjects: 55
Study 17251929 — intervention group
Group type: EXPERIMENTAL
Intervention: Native oat bran with 11.6 g native beta-glucans
Number of subjects: 9
Study 15364150 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved treatment reducing risk of restenosis and repeat revascularization
Number of subjects: 1642
Study 15364150 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher household income
Number of subjects: 1642
Study 11272848 — intervention group
Group type: EXPERIMENTAL
Intervention: c‐SPHP 3 g per day
Number of subjects: 21
Study 11272848 — intervention group
Group type: COMPARATOR
Intervention: c‐SPHP 0 g per day (placebo)
Number of subjects: 21
Study 9817340 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine 15 microg
Number of subjects: 5